Analyst Ratings for Teva Pharma (TEVA)
TEVA Rating Summary
TEVA Price Target Summary
- Highest: $48.00 (UBS)
- Lowest: $40.00 (Jefferies)
- Average: $42.90
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$42.90 (+16.4%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
Percentile Rank: 46%
Avg. $ Target:
$42.90 (+16.4%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
Percentile Rank: 46%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/9/2026 | Leerink | Daniel Clark | New Coverage | Outperform (N/A) |
45.00 (N/A) |
36.76 (36.85) |
0.24% | Details |
| 12/9/2025 | Barclays » Updated 8/12/2026 |
Glen Santangelo | New Coverage | Overweight (N/A) |
42.00 (40.00) |
28.46 (36.85) |
29.48% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
